Lucentis Bests Laser in DME (CME/CE)

(MedPage Today) -- Patients with diabetic macular edema (DME) treated with the costly drug ranibizumab (Lucentis) reported more clinically meaningful improvement in visual functioning than those who received laser treatments alone, according to a new study.
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news